Compare ARK Next Generation Internet ETF (ARKW) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Next Generation Internet ETF vs Moderna, Inc. — how do they compare? ARK Next Generation Internet ETF trades at $154.06, while Moderna, Inc. trades at $63.92 (market cap $25.42B). The key difference: Moderna, Inc. is trading nearer its 52-week high, ARK Next Generation Internet ETF nearer its low. Which is the better fit depends on your goals.
| ARKW | MRNA | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $182.20 | $81.80 |
52-Week Low | $114.45 | $22.36 |
Market Cap | — | $25.42B |
Enterprise Value | — | $21.57B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKW trades at $151.13, up 0.81% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF focuses on next-generation internet companies like AMD and Tesla, facing near-term headwinds from elevated AI and cloud infrastructure spending. Recent news highlights long-term growth potential in agentic AI and physical AI, despite current market skepticism.
The outlook for ARKW is cautiously optimistic, with long-term growth driven by AI and innovation themes, but near-term risks include capital expenditure pressures and market volatility. Investment opportunity lies in exposure to disruptive tech, while risks involve sector concentration and economic sensitivity.
Moderna (MRNA) trades at $63.65, up 5.09% on the day, with a bullish technical signal from moving averages and recent FDA approval of its mRNA flu vaccine mFLUSIVA for adults 50+. Despite negative net income margins and declining revenue since 2022, the company beat Q2 2026 EPS estimates and maintains a diversified pipeline in flu, oncology, and rare diseases. Cash flow improved in 2025 with positive net cash flow of $668 million.
The outlook hinges on pipeline execution beyond COVID-19, with growth opportunities in new vaccine approvals but significant risks from persistent losses and competitive pressures. Analyst consensus is cautious with a hold-heavy rating and $54.33 price target below the current price, indicating skepticism about near-term profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Next Generation Internet ETF
ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.
Read more on ARKW →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
